|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 前庭性偏头痛:诊断标准——Barany学会及国际头痛学会共识文件显示文摘本文提供了前庭性偏头痛的诊断标准,由Barany学会前庭疾患分类委员会及国际头痛学会(IHS)偏头痛分类分委员会共同制定。分类包括前庭性偏头痛及很可能的前庭性偏头痛。与IHS的常规程序相同,前庭性偏头痛作为一种新分类,将首先出现在第3版国际头痛分类(ICHD-3)的附录中。若积累了进一步的证据,很可能的前庭性偏头痛也许会纳入更晚的ICHD版本中。前庭性偏头痛的诊断建立在反复发作的前庭症状、具有偏头痛病史、前庭症状与偏头痛症状间存在时间上的相关性,并排除其他可导致前庭症状的病因。符合前庭性偏头痛诊断的症状包括不同类型的眩晕及头部活动诱发的头晕伴恶心。症状的严重程度必须为中重度。急性发作的持续时间限于5 min^72 h的时间窗内。 | 华驾略 李焰生 Lempert T Olesen J Furman J Waterston J Seemungal B Carey J Bisdorff A Versino M Evers S Newman-Toker D | 2013 | 神经病学与神经康复学杂志2013,10,3: | 60 |
| 2 | Systematic mechanism-orientated approach to chronic pancreatitis pain显示文摘Pain in chronic pancreatitis(CP) shows similarities with other visceral pain syndromes(i.e.,inflammatory bowel disease and esophagitis),which should thus be managed in a similar fashion.Typical causes of CP pain include increased intrapancreatic pressure,pancreatic inflammation and pancreatic/extrapancreatic complications.Unfortunately,CP pain continues to be a major clinical challenge.It is recognized that ongoing pain may induce altered central pain processing,e.g.,central sensitization or pro-nociceptive pain modulation.When this is present conventional pain treatment targeting the nociceptive focus,e.g.,opioid analgesia or surgical/endoscopic intervention,often fails even if technically successful.If central nervous system pain processing is altered,specific treatment targeting these changes should be instituted(e.g.,gabapentinoids,ketamine or tricyclic antidepressants).Suitable tools are now available to make altered central processing visible,including quantitative sensory testing,electroencephalograpy and(functional) magnetic resonance imaging.These techniques are potentially clinically useful diagnostic tools to analyze central pain processing and thus define optimum management approaches for pain in CP and other visceral pain syndromes.The present review proposes a systematic mechanism-orientated approach to pain management in CP based on a holistic view of the mechanisms involved.Future research should address the circumstances under which central nervous system pain processing changes in CP,and how this is influenced by ongoing nociceptive input and therapies.Thus we hope to predict which patients are at risk for developing chronic pain or not responding to therapy,leading to improved treatment of chronic pain in CP and other visceral pain disorders. | Stefan AW Bouwense Marjan de Vries Luuk TW Schreuder Soren S Olesen Jens B Frokjær Asbjorn M Drewes Harry van Goor Oliver HG Wilder-Smith | 2015 | World Journal of Gastroenterology2015,21,1: | 6 |
| 3 | Pain and chronic pancreatitis: A complex interplay of multiple mechanisms显示文摘Despite multiple theories on the pathogenesis of pain in chronic pancreatitis,no uniform and consistently successful treatment strategy exists and abdominal pain still remains the dominating symptom for most patients and a major challenge for clinicians.Traditional theories focussed on a mechanical cause of pain related to anatomical changes and evidence of increased ductal and interstitial pressures.These observations form the basis for surgical and endoscopic drainage procedures,but the outcome is variable and often unsatisfactory.This underscores the fact that other factors must contribute to pathogenesis of pain,and has shifted the focus towards a more complex neurobiological understanding of pain generation.Amongst other explanations for pain,experimental and human studies have provided evidence that pain perception at the peripheral level and central pain processing of the nociceptive information is altered in patients with chronic pancreatitis,and resembles that seen in neuropathic and chronic pain disorders.However,pain due to e.g.,complications to the disease and adverse effects to treatment must not be overlooked as an additional source of pain.This review outlines the current theories on pain generation in chronic pancreatitis which is crucial in order to understand the complexity and limitations of current therapeutic approaches.Furthermore,it may also serve as an inspiration for further research and development of methods that can evaluate the relative contribution and interplay of different pain mechanisms in the individual patients,before they are subjected to more or less empirical treatment. | Jakob Lykke Poulsen Sφren Schou Olesen Lasse Paludan Malver Jens Brφndum Frφkjr Asbjφrn Mohr Drewes | 2013 | World Journal of Gastroenterology2013,19,42: | 5 |
| 4 | Nutrition in chronic pancreatitis显示文摘The pancreas is a major player in nutrient digestion.In chronic pancreatitis both exocrine and endocrine insufficiency may develop leading to malnutrition over time.Maldigestion is often a late complication of chronic pancreatic and depends on the severity of the underlying disease.The severity of malnutrition is correlated with two major factors:(1)malabsorption and depletion of nutrients(e.g.,alcoholism and pain)causes impaired nutritional status;and(2)increased metabolic activity due to the severity of the disease.Nutritional deficiencies negatively affect outcome if they are not treated.Nutritional assessment and the clinical severity of the disease are important for planning any nutritional intervention.Good nutritional practice includes screening to identify patients at risk,followed by a thoroughly nutritional assessment and nutrition plan for risk patients.Treatment should be multidisciplinary and the mainstay of treatment is abstinence from alcohol,pain treatment,dietary modifications and pancreatic enzyme supplementation.To achieve energy-end protein requirements,oral supplementation might be beneficial.Enteral nutrition may be used when patients do not have sufficient calorie intake as in pylero-duodenalstenosis,inflammation or prior to surgery and can be necessary if weight loss continues.Parenteral nutrition is very seldom used in patients with chronic pancreatitis and should only be used in case of GI-tract obstruction or as a supplement to enteral nutrition. | Henrik Hφjgaard Rasmussen φivind Irtun Sφren Schou Olesen Asbjφrn Mohr Drewes Mette Holst | 2013 | World Journal of Gastroenterology2013,19,42: | 4 |
| 5 | Aging and menopause reprogram osteoclast precursors for aggressive bone resorption显示文摘Women gradually lose bone from the age of〜35 years,but around menopause,the rate of bone loss escalates due to increasing bone resorption and decreasing bone formation levels,rendering these individuals more prone to developing osteoporosis.The increased osteoclast activity has been linked to a reduced estrogen level and other hormonal changes.However,it is unclear whether intrinsic changes in osteoclast precursors around menopause can also explain the increased osteoclast activity.Therefore,we set up a protocol in which CD14f blood monocytes were isolated from 49 female donors(40-66 years old).Cells were differentiated into osteoclasts,and data on differentiation and resorption activity were collected.Using multiple linear regression analyses combining in vitro and in vivo data,we found the following:(1)age and menopausal status correlate with aggressive osteoclastic bone resorption in vitro;(2)the type I procollagen N-terminal propeptide level in vivo inversely correlates with osteoclast resorption activity in vitro;(3)the protein level of mature cathepsin K in osteoclasts in vitro increases with age and menopause;and(4)the promoter of the gene encoding the dendritic cell-specific transmembrane protein is less methylated with age.We conclude that monocytes are'reprogrammed'in vivo,allowing them to'remember'age,the menopausal status,and the bone formation status in vitro,resulting in more aggressive osteoclasts.Our discovery suggests that this may be mediated through DNA methylation.We suggest that this may have clinical implications and could contribute to understanding individual differences in age-and menopause-induced bone loss. | Anais Marie Julie Moller Jean-Marie Delaisse Jacob Bastholm Olesen Jonna Skov Madsen Luisa Matos Canto Troels Bechmann Silvia Regina Rogatto Kent Soe | 2020 | Bone Research2020,8,3: | 4 |
| 6 | Pharmacological challenges in chronic pancreatitis显示文摘Drug absorption in patients with chronic pancreatitis might be affected by the pathophysiology of the disease.The exocrine pancreatic insufficiency is associated with changes in gastrointestinal intraluminal pH,motility disorder,bacterial overgrowth and changed pancreatic gland secretion.Together these factors can result in malabsorption and may also affect the efficacy of pharmacological intervention.The lifestyle of chronic pancreatitis patients may also contribute to gastrointestinal changes.Many patients limit their food intake because of the pain caused by eating and in some cases food intake is more or less substituted with alcohol,tobacco and coffee.Alcohol and drug interaction are known to influence the pharmacokinetics by altering either drug absorption or by affecting liver metabolism.Since patients suffering from chronic pancreatitis experience severe pain,opioids are often prescribed as pain treatment.Opioids have intrinsic effects on gastrointestinal motility and hence can modify the absorption of other drugs taken at the same time.Furthermore,the increased fluid absorption caused by opioids will decrease water available for drug dissolution and may hereby affect absorption of the drug.As stated above many factors can influence drug absorption and metabolism in patients with chronic pancreatitis.The factors may not have clinical relevance,but may explain inter-individual variations in responses to a given drug,in patients with chronic pancreatitis. | Anne Estrup Olesen Anne Brokjaer Iben WD Fisher Isabelle M Larsen | 2013 | World Journal of Gastroenterology2013,19,42: | 3 |
| 7 | Evaluation of a new qPCR test to identify the organisms causing high total bacterial count in bulk tank milk显示文摘Milk quality in bulk tank milk(BTM)is measured by flow cytometry technology as total bacterial count(TBC)and somatic cell count(SCC).To investigate SCC problems,culture or PCR can be used to identify mastitis causing bacteria,e.g.,Mastit 4,a commercially available qPCR test.TBC in BTM can be investigated further using culture-based methods such as standard plate count,laboratory pasteurization count,coliform count,and spore counts.To our knowledge,no qPCR addressing the bacteria involved in TBC has been commercially introduced.The aim of this study is to evaluate a recently introduced 3-h qPCR test,TBC 4.The TBC 4 qPCR detects four target groups,Pseudomonas,Streptococci,Enterobacteriacea/Enterococcus,and Bacillus/Clostridia.These target groups relate to problems on the farm such as cooling,mastitis,environment,and silage.We will continue with new research to compare the TBC 4 qPCR test with traditional culture.For this study,BTM samples from different TBC intervals were selected based on Bacto Count results found at routine payment investigation at Eurofins laboratory(Vejen,Denmark).These samples were analyzed using TBC 4 qPCR assay within 24 h.In total,346 BTM samples were divided into six different intervals of colony forming units(CFU).For all four targets in each of the different intervals of CFU,the percent of positive samples,the average C_t-value,the percent of positive samples with C_t<30 and C_t<25 were calculated.For Pseudomonas,Streptococci,and Enterobacteriacea/Enterococcus,the number of positive samples with lower C_t-values(high bacteria content)correlated with the CFU mL^(–1).We found Enterobacteriacea/Enterococcus,Pseudomonas,and Streptococci in high number of bacteria(C_t<25)in 25,19 and 56%of samples with CFU mL^(–1) between 50 001–100 000 and 53,44,and 39%in samples with CFU mL^(–1)>100 000.The TBC 4 qPCR test showed to be a strong and fast tool for farmers,advisors and service technicians to address problems with high TBC and ensuring the delivery of good quality milk to the dairy. | Jorgen Katholm Lene Trier Olesen Anders Petersen Snorri Sigurdsson | 2018 | Journal of Integrative Agriculture2018,17,6: | 3 |
| 8 | Translational pain research: Evaluating analgesic effect in experimental visceral pain models显示文摘Deep visceral pain is frequent and presents major challenges in pain management, since its pathophysiology is still poorly understood. One way to optimize treatment of visceral pain is to improve knowledge of the mechanisms behind the pain and the mode of action of analgesic substances. This can be achieved through stand-ardized experimental human pain models. Experimental pain models in healthy volunteers are advantageous for evaluation of analgesic action, as this is often diff icult to assess in the clinic because of confounding factors such as sedation, nausea and general malaise. These pain models facilitate minimizing the gap between knowledge gained in animal and human clinical studies. Combining experimental pain studies and pharmacokinetic stud- ies can improve understanding of the pharmacokinetic-pharmacodynamic relationship of analgesics and, thus, provide valuable insight into optimal clinical treatment of visceral pain. To improve treatment of visceral pain, it is important to study the underlying mechanisms of pain and the action of analgesics used for its treatment. An experimental pain model activates different modalities and can be used to investigate the mechanism of action of different analgesics in detail. In combination with pharmacokinetic studies and objective assessment such as electroencephalography, new information re-garding a given drug substance and its effects can be obtained. Results from experimental human visceral pain research can bridge the gap in knowledge between animal studies and clinical condition in patients suffering from visceral pain, and thus constitute the missing link in translational pain research. | Anne Estrup Olesen Trine Andresen Lona Louring Christrup Richard N Upton | 2009 | World Journal of Gastroenterology2009,15,2: | 3 |
| 9 | The prevalence of Human Papillomavirus in colorectal adenomas and adenocarcinomas: A systematic review and meta-analysis显示文摘 | Louise Baandrup Louise T. Thomsen Tina Bech Olesen Klaus Kaae Andersen Bodil Norrild Susanne K. Kjaer | 2014 | European Journal of Cancer2014,,: | 2 |
| 10 | Pretreatment of wheat straw using combined wet oxidation and alkaline hydrolysis resulting in convertible cellulose and hemicellulose显示文摘 | Bjerre AB Olesen AB Fernqvist Ploger A | 1996 | Bioresour Technol1996,49,: | 2 |
| 11 | 年龄和靶器官损害对24h动态血压预后价值的影响显示文摘靶器官损害标志物和测量24h动态血压可以改善心血管风险分层。随着年龄的增长,靶器官损害和血压升高的发病率增加。该研究目的是评估年龄和靶器官损害对动态血压预测预后价值的影响。 | 黄洁 叶鹏 Olesen TB Stidsen JV Blicher MK Pareek M Rasmussen S Vishram-Nielsen JKK Olsen MH | 2017 | 中华高血压杂志2017,25,10: | 2 |
| 12 | Generation of flavour compounds in fermented sausages—the influence of curing ingredients, Staphylococcus starter culture and ripening time显示文摘 | Pelle Thonning Olesen Anne Strunge Meyer Louise Heller Stahnke | 2003 | Meat Science2003,,3: | 2 |
| 13 | Clinical and pathophysiological observations in migraine and tension -type headache explained by integration of vascular,supraspinal and myofascial inputs 显示文摘 | Olesen J | 1991 | Pain1991,46,2: | 1 |
| 14 | Bayesian updating in causal probabilistic networks by local computation显示文摘 | Jensen F V Lauritzen S Olesen K | 1990 | Computational Statistics Quarterly1990,,4: | 1 |
| 15 | The mannan- binding lectin pathway and lung disease in cystic fibrosis-disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier 显示文摘 | Olesen HV Jensenius JC Steffensen R | 2006 | Clin Immunol2006,121,3: | 1 |
| 16 | Characterization and expression of recombination activating genes (RAG21 and RAG22) in Xenopus laevis 显示文摘 | Greenhalgh P CEM Olesen LA Steiner | 1993 | J Immunol1993,151,: | 1 |
| 17 | AC electrokinetic micropumps: the effect of geometrical confinement, faradaie current injection and nonlinear surface capacitance 显示文摘 | OLESEN L H BRUUS H AJDARI A | 2006 | Phys Rev: E2006,73,5: | 1 |
| 18 | Pretreatment of wheat straw using combined wet oxidation and alkaline hydrolysis resulting in convertible cellulose and hemiceUulose显示文摘 | BJERRE A B OLESEN A B FERNQVIST T | 1996 | Biotechnology and Bioengineering1996,49,5: | 1 |
| 19 | High Resolution Time Series of IR Data from a Combination of AVHRR and METEOSAT 显示文摘 | Olesen F S Kind O Reutter H | 1995 | Advances in Space Research1995,16,10: | 1 |
| 20 | The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache 显示文摘 | Jes Olesen | 2008 | Pharmacology & Therapeutics2008,120,: | 1 |